Psilocybin, the key psychoactive compound in magic mushrooms, remains a federally-managed Plan I drug; this means that psilocybin mushrooms are viewed as to possess no medically approved use and carry a substantial opportunity for abuse. But FDA-approved trials for that selected breakthrough therapy proceed immediately after studies found psilocybi